Marini, Joseph C
1609  Ergebnisse:
Personensuche X
?
2

P049 COMPARISON OF USTEKINUMAB CONCENTRATION ASSAYS AND ANT..:

Marini, Joseph C ; Chun, Kelly Y ; Rebarchak, Shannon...
Inflammatory Bowel Diseases.  25 (2019)  Supplement_1 - p. S24-S25 , 2019
 
?
 
?
7

Pharmacokinetics, pharmacodynamics and safety of a human an..:

Xu, Zhenhua ; Bouman‐Thio, Esther ; Comisar, Craig...
British Journal of Clinical Pharmacology.  72 (2011)  2 - p. 270-281 , 2011
 
?
8

Subcutaneous Bioavailability of Golimumab at 3 Different In..:

Xu, Zhenhua ; Wang, Qingmin ; Zhuang, Yanli...
The Journal of Clinical Pharmacology.  50 (2010)  3 - p. 276-284 , 2010
 
?
10

Population Pharmacokinetic Modeling of Ustekinumab, a Human..:

Zhu, Yaowei ; Hu, Chuanpu ; Lu, Ming...
The Journal of Clinical Pharmacology.  49 (2009)  2 - p. 162-175 , 2009
 
?
11

Pharmacokinetics and Safety of Golimumab, a Fully Human Ant..:

Zhou, Honghui ; Jang, Haishan ; Fleischmann, Roy M....
The Journal of Clinical Pharmacology.  47 (2007)  3 - p. 383-396 , 2007
 
?
12

Role of tumor necrosis factor-α in graft-versus-host diseas..:

Korngold, Robert ; Marini, Joseph C ; de Baca, Monica E..
Biology of Blood and Marrow Transplantation.  9 (2003)  5 - p. 292-303 , 2003
 
?
13

Prevention of experimental allergic encephalomyelitis by ta..:

Hooper, D. Craig ; Bagasra, Omar ; Marini, Joseph C....
Proceedings of the National Academy of Sciences.  94 (1997)  6 - p. 2528-2533 , 1997
 
?
14

Prevention of Experimental Allergic Encephalomyelitis by Ta..:

Hooper, D. Craig ; Bagasra, Omar ; Marini, Joseph C....
Proceedings of the National Academy of Sciences of the United States of America.  94 (1997)  6 - p. 2528-2533 , 1997
 
1-15